Canadian HIV & Viral Hepatitis Pharmacists Network (CHAP) Resources
References and Resources for Trainees
Antiretroviral Reimbursement
- Reimbursement status of antiretrovirals in Canada
- Reimbursement status of PrEP in Canada
- Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study. Yoong D et al. CMAJ Open 2018;6:E551-560.
- CHAP position statement on Universal Access to Antiretroviral Drugs in Canada (2017)
Tools/Resources
- Antiretroviral Reference Tool for Pharmacists
- A Management Tool for HIV Drug-Drug Interactions – English
- A Management Tool for HIV Drug-Drug Interactions – French
- Medication Reconciliation Form (MedsCheck) – 2015 Version, English
- Quebec Antiretroviral Therapeutic Drug Monitoring Program – English
- Quebec Antiretroviral Therapeutic Drug Monitoring Program – French
- A Tool for Preventing and Managing Bone Disease in HIV-infected Adults
- A Guide to Assessing Antiretroviral Therapy in HIV Hospitalized Patients
- A Guide to Assessing Antiretroviral Therapy in HIV Hospitalized Patients – Pocket Card
CHAP Chats
- November 2023: Hepatitis C: it can still be challenging (J. Feld)
- March 2023: Infant feeding in HIV (S. Khan)
- June 2022: A pharmacist’s guide to the use of dual-therapy regimens for HIV infection (CCCEP#: 1329-2022-3369-I-P) (S. Campbell)
- December 2021: Antiretroviral resistance: cases (S. Shafran)
- September 2021: COVID vaccines and variants (A. Sharkawy)
- June 2021: HIV and aging (S. Walmsley) – slides
- May 2021: HIV and pediatrics (J. Brophy) – slides
- April 2021: HCV update (D. Martel) – HCV CHAP 2021
- March 2021: What to do about M184V? (C. Brumme); Resistance case (L. Akagi)
- February 2021: Antiretrovirals in Pregnancy (K. Tulloch); Overview of Women-Centred HIV Care Toolkits (M. Loutfy & M. Ndung’u)
Goals:
To promote cross-country sharing of experiences and information to improve patient care.
To develop practical, clinical guidelines on the role of the pharmacist in caring for patients with HIV and/or viral hepatitis.
To collaborate on research protocols which demonstrate positive drug-related outcomes.
To share continuing education resources, in order to make information on HIV and/or viral hepatitis drug therapy more accessible to community, hospital and ambulatory pharmacists, as well as patients.
To foster the development of HIV and/or viral hepatitis pharmacist mentors.
To promote the pharmacists role in HIV and/or viral hepatitis therapeutics on a national level.